TNF inhibitors may help prevent diabetes in RA patients

10/13/2011 | Medscape (free registration)

Patients with rheumatoid arthritis who received tumor necrosis factor inhibitors were less likely to develop type 2 diabetes within the next three to four years than those who did not take the drug, according to a study in Arthritis Care & Research. Researchers studied 1,587 RA patients and found that 91 developed diabetes, 16 of whom used TNF inhibitors and 75 of whom did not.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care